

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.06297099 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.93468488 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.93468488 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.51203055 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.48112013 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.43063796 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.08395343 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.83024034 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.83024034 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.83024034 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.83024034 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.83024034 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.83024034 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.80805500 |
| 15 | detection of other organism (GO:0098543) | 4.69115699 |
| 16 | detection of bacterium (GO:0016045) | 4.68349077 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.61996271 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.46038784 |
| 19 | response to peptidoglycan (GO:0032494) | 4.45858709 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.43438020 |
| 21 | leukocyte aggregation (GO:0070486) | 4.38845870 |
| 22 | positive thymic T cell selection (GO:0045059) | 4.17595327 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.16316887 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.11493212 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 4.06631135 |
| 26 | negative thymic T cell selection (GO:0045060) | 4.01660460 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 3.98913613 |
| 28 | cellular extravasation (GO:0045123) | 3.94979331 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.88105044 |
| 30 | negative T cell selection (GO:0043383) | 3.84262348 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84169790 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.78038897 |
| 33 | thymic T cell selection (GO:0045061) | 3.72066318 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.69225594 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.63968304 |
| 36 | T cell selection (GO:0045058) | 3.63759182 |
| 37 | response to interleukin-15 (GO:0070672) | 3.61169777 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57055988 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.55587940 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.55064378 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.49565750 |
| 42 | respiratory burst (GO:0045730) | 3.49403785 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.49048213 |
| 44 | positive T cell selection (GO:0043368) | 3.46935950 |
| 45 | germinal center formation (GO:0002467) | 3.43835287 |
| 46 | neutrophil activation (GO:0042119) | 3.40791248 |
| 47 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40787199 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40586270 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 3.38554588 |
| 50 | response to host immune response (GO:0052572) | 3.34974563 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.34974563 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.31821002 |
| 53 | T cell migration (GO:0072678) | 3.30603237 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 3.27879086 |
| 55 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.27202789 |
| 56 | detection of biotic stimulus (GO:0009595) | 3.24412322 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.23230910 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.19336342 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19046663 |
| 60 | response to host (GO:0075136) | 3.19046663 |
| 61 | response to host defenses (GO:0052200) | 3.19046663 |
| 62 | mannose metabolic process (GO:0006013) | 3.18849036 |
| 63 | tolerance induction (GO:0002507) | 3.15470940 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.13208028 |
| 65 | granulocyte activation (GO:0036230) | 3.10454499 |
| 66 | cellular response to interleukin-15 (GO:0071350) | 3.09809243 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 3.08299424 |
| 68 | cellular response to type I interferon (GO:0071357) | 3.05981483 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.05981483 |
| 70 | response to type I interferon (GO:0034340) | 3.05902221 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.01732711 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.01144935 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 3.00523964 |
| 74 | detection of molecule of bacterial origin (GO:0032490) | 2.98320696 |
| 75 | regulation of regulated secretory pathway (GO:1903305) | 2.94995735 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94886909 |
| 77 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91916224 |
| 78 | defense response to protozoan (GO:0042832) | 2.90348439 |
| 79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90246217 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87968645 |
| 81 | leukocyte degranulation (GO:0043299) | 2.87630972 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.87517977 |
| 83 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.86533745 |
| 84 | negative regulation of innate immune response (GO:0045824) | 2.81449771 |
| 85 | macrophage activation (GO:0042116) | 2.81141400 |
| 86 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79713964 |
| 87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79677629 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.78997022 |
| 89 | T cell homeostasis (GO:0043029) | 2.77667282 |
| 90 | activated T cell proliferation (GO:0050798) | 2.77179781 |
| 91 | B cell mediated immunity (GO:0019724) | 2.76646768 |
| 92 | negative regulation of interleukin-6 production (GO:0032715) | 2.76466992 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 2.76068780 |
| 94 | positive regulation of Rap GTPase activity (GO:0032854) | 2.75080406 |
| 95 | microglial cell activation (GO:0001774) | 2.73557263 |
| 96 | negative regulation of type 2 immune response (GO:0002829) | 2.73467770 |
| 97 | regulation of mast cell activation (GO:0033003) | 2.72900057 |
| 98 | response to protozoan (GO:0001562) | 2.72695862 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.71266760 |
| 100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.71266760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.95485171 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.75579281 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.54241317 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18920046 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05807527 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00998541 |
| 7 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.88403869 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.61376315 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.59188366 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54822849 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.53711279 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49751289 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.48427891 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44441664 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40835091 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.36039728 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.35607004 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.31849956 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27973993 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27305472 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27015695 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23263229 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23045522 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22327112 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.20120574 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17986405 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17831095 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17192879 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17075412 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16837000 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13231049 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.10483623 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09152449 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07736823 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.04207242 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 2.03637444 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02701407 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 2.01900929 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96414195 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.90793663 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88512186 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85448280 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85079978 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85064853 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77018851 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66046824 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65104990 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.63191265 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54991903 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43959205 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42418356 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41178281 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41106211 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40604340 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38628410 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36828418 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36091037 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33705685 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32161746 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29600242 |
| 61 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28808641 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28235435 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26320420 |
| 64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25669390 |
| 65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25542019 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 1.25391245 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25134543 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25123361 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24475596 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24253087 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24211164 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23564040 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22354041 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18970197 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13745716 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13255971 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12948674 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11834913 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11289427 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09665672 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06836826 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04804398 |
| 83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03907446 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03131650 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02713518 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02710041 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00711181 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00308783 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99285661 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97834931 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95729366 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95515786 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93180652 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92717380 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92110499 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91745090 |
| 97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90668436 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89352309 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88531734 |
| 100 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87744622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.14933498 |
| 2 | MP0003303_peritoneal_inflammation | 3.55397440 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.52735078 |
| 4 | MP0003724_increased_susceptibility_to | 3.34961680 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.98030827 |
| 6 | MP0001800_abnormal_humoral_immune | 2.88627993 |
| 7 | MP0002419_abnormal_innate_immunity | 2.83170011 |
| 8 | MP0000685_abnormal_immune_system | 2.81868939 |
| 9 | MP0005387_immune_system_phenotype | 2.75916487 |
| 10 | MP0001790_abnormal_immune_system | 2.75916487 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.75109645 |
| 12 | MP0005671_abnormal_response_to | 2.75073546 |
| 13 | MP0005025_abnormal_response_to | 2.73988813 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.61315535 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.51783486 |
| 16 | MP0001819_abnormal_immune_cell | 2.48717375 |
| 17 | MP0002723_abnormal_immune_serum | 2.48390629 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.42281144 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.35202165 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.30430326 |
| 21 | MP0009785_altered_susceptibility_to | 2.23907258 |
| 22 | MP0009278_abnormal_bone_marrow | 2.16722353 |
| 23 | MP0002398_abnormal_bone_marrow | 2.15439505 |
| 24 | MP0006082_CNS_inflammation | 2.07682524 |
| 25 | MP0008260_abnormal_autophagy | 2.05118244 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.03684363 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.02232299 |
| 28 | MP0000716_abnormal_immune_system | 1.98876583 |
| 29 | MP0005451_abnormal_body_composition | 1.98235492 |
| 30 | MP0004947_skin_inflammation | 1.97316084 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.94994821 |
| 32 | MP0002405_respiratory_system_inflammati | 1.93887243 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.90918313 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.86339891 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.83181012 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.76837691 |
| 37 | MP0002722_abnormal_immune_system | 1.74829817 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.72489368 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.70509828 |
| 40 | MP0003866_abnormal_defecation | 1.69240423 |
| 41 | MP0002429_abnormal_blood_cell | 1.62829362 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.62581146 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.61928519 |
| 44 | MP0001873_stomach_inflammation | 1.58248185 |
| 45 | MP0005310_abnormal_salivary_gland | 1.56733794 |
| 46 | MP0003828_pulmonary_edema | 1.51083279 |
| 47 | MP0004381_abnormal_hair_follicle | 1.50851792 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.46896246 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.46475102 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.42174715 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.42174715 |
| 52 | MP0002009_preneoplasia | 1.38071853 |
| 53 | MP0000858_altered_metastatic_potential | 1.35525083 |
| 54 | MP0001851_eye_inflammation | 1.34520920 |
| 55 | MP0002132_abnormal_respiratory_system | 1.34168740 |
| 56 | MP0004510_myositis | 1.29391511 |
| 57 | MP0008469_abnormal_protein_level | 1.28272070 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.27521130 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.26766138 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.24534725 |
| 61 | MP0000490_abnormal_crypts_of | 1.11247917 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.09772641 |
| 63 | MP0001853_heart_inflammation | 1.08747149 |
| 64 | MP0003075_altered_response_to | 1.05334470 |
| 65 | MP0002006_tumorigenesis | 0.99805292 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 0.96530694 |
| 67 | MP0005166_decreased_susceptibility_to | 0.94897814 |
| 68 | MP0003690_abnormal_glial_cell | 0.93505387 |
| 69 | MP0002933_joint_inflammation | 0.91094944 |
| 70 | MP0004883_abnormal_blood_vessel | 0.89131846 |
| 71 | MP0001663_abnormal_digestive_system | 0.87057402 |
| 72 | MP0009840_abnormal_foam_cell | 0.86430672 |
| 73 | MP0000604_amyloidosis | 0.85334564 |
| 74 | MP0009764_decreased_sensitivity_to | 0.83789446 |
| 75 | MP0003091_abnormal_cell_migration | 0.80720373 |
| 76 | MP0003045_fibrosis | 0.77127817 |
| 77 | MP0003448_altered_tumor_morphology | 0.75490328 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.75369414 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.74930225 |
| 80 | MP0005390_skeleton_phenotype | 0.72857374 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.69996721 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.69931901 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.68506845 |
| 84 | MP0001849_ear_inflammation | 0.66795218 |
| 85 | MP0009763_increased_sensitivity_to | 0.66236854 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.65800734 |
| 87 | MP0008874_decreased_physiological_sensi | 0.65566529 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.65558443 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.64737291 |
| 90 | MP0004130_abnormal_muscle_cell | 0.63948941 |
| 91 | MP0003795_abnormal_bone_structure | 0.62680183 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.60481557 |
| 93 | MP0000249_abnormal_blood_vessel | 0.60411010 |
| 94 | MP0003329_amyloid_beta_deposits | 0.59848308 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.59534833 |
| 96 | MP0004858_abnormal_nervous_system | 0.59523954 |
| 97 | MP0005164_abnormal_response_to | 0.58815789 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.55524322 |
| 99 | MP0008004_abnormal_stomach_pH | 0.54041989 |
| 100 | MP0005381_digestive/alimentary_phenotyp | 0.52162766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.15972467 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.12557783 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.02958521 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.54775722 |
| 5 | Myositis (HP:0100614) | 4.45233327 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.00282027 |
| 7 | Meningitis (HP:0001287) | 3.92632484 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.90305185 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87221666 |
| 10 | Orchitis (HP:0100796) | 3.82872820 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.81296159 |
| 12 | Obstructive lung disease (HP:0006536) | 3.78092376 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.78092376 |
| 14 | Increased IgE level (HP:0003212) | 3.77904108 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.73017834 |
| 16 | Cellulitis (HP:0100658) | 3.69561865 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.53714815 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.49905525 |
| 19 | Optic neuritis (HP:0100653) | 3.49905525 |
| 20 | Stomatitis (HP:0010280) | 3.48947236 |
| 21 | Recurrent skin infections (HP:0001581) | 3.45954164 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.36037671 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.36037671 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.35937530 |
| 25 | Recurrent viral infections (HP:0004429) | 3.35023718 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.31584737 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.24739808 |
| 28 | Gingivitis (HP:0000230) | 3.19566017 |
| 29 | Colitis (HP:0002583) | 3.17380371 |
| 30 | Encephalitis (HP:0002383) | 3.15959042 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.15943416 |
| 32 | Vasculitis (HP:0002633) | 3.14995050 |
| 33 | Prolonged bleeding time (HP:0003010) | 3.11079522 |
| 34 | Agammaglobulinemia (HP:0004432) | 3.02974776 |
| 35 | Pustule (HP:0200039) | 3.02282391 |
| 36 | Urticaria (HP:0001025) | 2.90010249 |
| 37 | Chest pain (HP:0100749) | 2.86286463 |
| 38 | Hypochromic anemia (HP:0001931) | 2.64094179 |
| 39 | Osteomyelitis (HP:0002754) | 2.63587630 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 2.61639359 |
| 41 | T lymphocytopenia (HP:0005403) | 2.59287912 |
| 42 | Epistaxis (HP:0000421) | 2.57401831 |
| 43 | Granulocytopenia (HP:0001913) | 2.56403133 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.55011190 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.51173681 |
| 46 | Lymphopenia (HP:0001888) | 2.45287937 |
| 47 | Abnormality of T cells (HP:0002843) | 2.45034691 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.43249877 |
| 49 | Hemoptysis (HP:0002105) | 2.42214079 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.39998452 |
| 51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36527203 |
| 52 | Verrucae (HP:0200043) | 2.34813413 |
| 53 | Papilloma (HP:0012740) | 2.34813413 |
| 54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.32817200 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.32295880 |
| 56 | Leukocytosis (HP:0001974) | 2.29936845 |
| 57 | Sepsis (HP:0100806) | 2.28735879 |
| 58 | Arterial thrombosis (HP:0004420) | 2.28462028 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.27371677 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.27342997 |
| 61 | Viral hepatitis (HP:0006562) | 2.25383924 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.24593368 |
| 63 | Gingival bleeding (HP:0000225) | 2.24578418 |
| 64 | Episodic fever (HP:0001954) | 2.22789616 |
| 65 | Amyloidosis (HP:0011034) | 2.21994905 |
| 66 | Petechiae (HP:0000967) | 2.21088373 |
| 67 | Pulmonary embolism (HP:0002204) | 2.19207772 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.18184936 |
| 69 | Skin ulcer (HP:0200042) | 2.08530155 |
| 70 | Papilledema (HP:0001085) | 2.07220363 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 2.05395303 |
| 72 | Obstructive sleep apnea (HP:0002870) | 2.05146763 |
| 73 | IgM deficiency (HP:0002850) | 2.04344915 |
| 74 | Polygenic inheritance (HP:0010982) | 2.04058003 |
| 75 | Increased IgM level (HP:0003496) | 2.00939035 |
| 76 | Restrictive lung disease (HP:0002091) | 1.99960216 |
| 77 | Purpura (HP:0000979) | 1.99762060 |
| 78 | Dysostosis multiplex (HP:0000943) | 1.99526895 |
| 79 | Hepatosplenomegaly (HP:0001433) | 1.94287448 |
| 80 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91186842 |
| 81 | Increased serum ferritin (HP:0003281) | 1.90614388 |
| 82 | Microcytic anemia (HP:0001935) | 1.89810811 |
| 83 | Anorexia (HP:0002039) | 1.88122898 |
| 84 | Loss of speech (HP:0002371) | 1.87649202 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 1.86473471 |
| 86 | Metaphyseal cupping (HP:0003021) | 1.86159669 |
| 87 | Premature loss of primary teeth (HP:0006323) | 1.85959937 |
| 88 | Autoimmune hemolytic anemia (HP:0001890) | 1.84882989 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84643014 |
| 90 | Recurrent bronchitis (HP:0002837) | 1.83840963 |
| 91 | Hypertensive crisis (HP:0100735) | 1.83076534 |
| 92 | Emphysema (HP:0002097) | 1.82401320 |
| 93 | Abnormality of the pleura (HP:0002103) | 1.82046512 |
| 94 | Fatigue (HP:0012378) | 1.80138428 |
| 95 | Broad face (HP:0000283) | 1.79294010 |
| 96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.78890766 |
| 97 | Skin rash (HP:0000988) | 1.77658076 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 1.75665687 |
| 99 | Hypermelanotic macule (HP:0001034) | 1.73883586 |
| 100 | Eosinophilia (HP:0001880) | 1.73792259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.27623593 |
| 2 | MAP4K1 | 3.94673510 |
| 3 | PRPF4B | 3.80200557 |
| 4 | ERN1 | 3.11488902 |
| 5 | TRIB3 | 2.81282980 |
| 6 | MAP2K3 | 2.49085040 |
| 7 | TYK2 | 2.34046010 |
| 8 | TNK2 | 2.32981468 |
| 9 | BLK | 2.31426918 |
| 10 | IRAK4 | 2.28024902 |
| 11 | FES | 2.25372148 |
| 12 | SMG1 | 1.99204456 |
| 13 | MAP3K13 | 1.95276957 |
| 14 | GRK6 | 1.90010283 |
| 15 | ZAP70 | 1.86334246 |
| 16 | CSK | 1.85422240 |
| 17 | TAOK1 | 1.80865092 |
| 18 | BTK | 1.73968902 |
| 19 | MAP3K14 | 1.59895551 |
| 20 | SIK1 | 1.46463813 |
| 21 | SYK | 1.46201556 |
| 22 | MAP3K11 | 1.43398240 |
| 23 | JAK3 | 1.41935094 |
| 24 | HCK | 1.41012482 |
| 25 | MAP3K10 | 1.40688369 |
| 26 | MARK2 | 1.40398586 |
| 27 | EPHB1 | 1.39381843 |
| 28 | MAP3K3 | 1.34976149 |
| 29 | SIK3 | 1.34365865 |
| 30 | TBK1 | 1.33836249 |
| 31 | CDK12 | 1.32543098 |
| 32 | SIK2 | 1.31046232 |
| 33 | IKBKE | 1.21350219 |
| 34 | MAP3K1 | 1.19854709 |
| 35 | JAK1 | 1.18097633 |
| 36 | KSR2 | 1.14244565 |
| 37 | CSF1R | 1.13818567 |
| 38 | PRKD2 | 1.10882855 |
| 39 | TXK | 1.09155231 |
| 40 | KIT | 1.07616042 |
| 41 | FGFR4 | 1.06983491 |
| 42 | ITK | 1.06853140 |
| 43 | LYN | 1.05184721 |
| 44 | JAK2 | 1.02701825 |
| 45 | FGR | 1.02651813 |
| 46 | EEF2K | 1.01925955 |
| 47 | LCK | 1.00190505 |
| 48 | TAOK2 | 0.95714361 |
| 49 | ICK | 0.93967535 |
| 50 | MAPK12 | 0.93481732 |
| 51 | PTK6 | 0.93132499 |
| 52 | PDK1 | 0.92984295 |
| 53 | PKN2 | 0.89705786 |
| 54 | IRAK2 | 0.88722809 |
| 55 | PDPK1 | 0.88197172 |
| 56 | CDC42BPA | 0.85458244 |
| 57 | CAMKK1 | 0.85038968 |
| 58 | MAP3K7 | 0.84702777 |
| 59 | TESK2 | 0.83223540 |
| 60 | HIPK2 | 0.82301308 |
| 61 | IRAK3 | 0.78264995 |
| 62 | MARK3 | 0.75844887 |
| 63 | TEC | 0.72597650 |
| 64 | FGFR3 | 0.70500342 |
| 65 | TAOK3 | 0.69823076 |
| 66 | LRRK2 | 0.69429465 |
| 67 | CDK4 | 0.68350141 |
| 68 | YES1 | 0.66931194 |
| 69 | STK10 | 0.66648248 |
| 70 | MAPK7 | 0.66213565 |
| 71 | IKBKB | 0.65426657 |
| 72 | MAP3K6 | 0.62740936 |
| 73 | CAMK1D | 0.61655381 |
| 74 | IRAK1 | 0.58421638 |
| 75 | RPS6KL1 | 0.58339612 |
| 76 | RPS6KC1 | 0.58339612 |
| 77 | RET | 0.57246189 |
| 78 | RIPK1 | 0.54608212 |
| 79 | MAPK11 | 0.54600561 |
| 80 | FYN | 0.52942842 |
| 81 | MATK | 0.52879463 |
| 82 | BMPR2 | 0.52610871 |
| 83 | MAP2K2 | 0.51288435 |
| 84 | CDK6 | 0.49430074 |
| 85 | PRKCQ | 0.47807211 |
| 86 | SGK3 | 0.47475759 |
| 87 | STK11 | 0.43262228 |
| 88 | RPS6KA6 | 0.43207160 |
| 89 | TTN | 0.42566985 |
| 90 | DYRK1B | 0.41972295 |
| 91 | CDK19 | 0.41776639 |
| 92 | RPS6KA2 | 0.39399765 |
| 93 | MAP3K8 | 0.39341987 |
| 94 | PRKCH | 0.38324434 |
| 95 | MAP3K2 | 0.35881477 |
| 96 | PIM1 | 0.35645976 |
| 97 | RAF1 | 0.34393443 |
| 98 | MAPK4 | 0.33799994 |
| 99 | MAP2K6 | 0.33162745 |
| 100 | PASK | 0.31586797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.61684738 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57979685 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56436844 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25607838 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.18967862 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.09498004 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.06178815 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06056791 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04272445 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97865484 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95589181 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94368382 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.84182454 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.82219742 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.77815800 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73698507 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72591290 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.63120658 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.56702525 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53981650 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49886549 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.47682128 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47532946 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46540577 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46492008 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.46336341 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45662686 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43639152 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36854673 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34696066 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32261354 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32248145 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32196462 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29156039 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26162479 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.26035495 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.24433210 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.22251428 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22122327 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20667981 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16150505 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14533521 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.13510822 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09935001 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.08948034 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05780478 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03583386 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02116169 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94632396 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.93929634 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93912823 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92665691 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92394914 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.91978292 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91386967 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.91044074 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89497404 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89132754 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86280359 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85898037 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85697771 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.84149822 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.80751881 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80510647 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79466090 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78918844 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78286634 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78169026 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77869519 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.76970112 |
| 71 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73722059 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.73524101 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71933948 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70818695 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.68823398 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68161438 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67993011 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67437455 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.65199499 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64255172 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.63583280 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62101884 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61867913 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61736359 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60593439 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.60255376 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60217846 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58036554 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56336708 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56207543 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55247235 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54387452 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54112027 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53758098 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.53372869 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53055959 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52243559 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51293776 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46993026 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46423396 |

